Blog

AI Scribes Cut EHR Time for Surgeons and Boost Visits

Adopting AI-powered scribes can streamline electronic health record tasks for surgical practices and enhance patient volume.

  • Clinicians using AI scribes spent 13.4 fewer minutes on EHRs weekly and reduced documentation time by 16 minutes.
  • On average, they saw 0.49 more patients per week.

Surgeons may benefit from integrating AI tools to improve efficiency and patient throughput.

  • Benefits were most pronounced among primary care and advanced practice clinicians.

Journal Article by Rotenstein LS, Holmgren AJ (…) Mishuris RG et 28 al. in JAMA

read the whole article in JAMA

open it in PubMed

No Long-Term Outcome Difference in Gallbladder Cancer Resection

Surgeons can expect similar long-term outcomes when choosing between segment 4b/5 and wedge resection for gallbladder adenocarcinoma.

  • 163 patients underwent randomized surgeries; segment 4b/5 took longer (318 min vs. 287 min) and had higher blood loss (265 ml vs. 223 ml).
  • No differences in morbidity, mortality, or R0 resection rates were observed.
  • At 27 months follow-up, mean disease-free survival was 41.8 months (4b/5) vs. 44.7 months (wedge), and mean overall survival was 45.3 months (4b/5) vs. 50.7 months (wedge).

Surgeons can select either technique without impacting oncological outcomes.

Clinical Trial, Phase III by Singh S, Aggarwal A (…) Talwar V et 2 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

New Biliary Drainage Technique for Altered Anatomy Shows Promise

A novel endoscopic approach improves biliary drainage outcomes for patients with altered anatomy.

  • Technical success rate: 87.3%, clinical success: 93.8%.
  • Adverse event rate: 20%, with 30.6% persistent fistula rate within 3 months.

Consider this technique for patients with complex anatomy, especially when multiple biliary interventions are needed.

  • Most common indication: benign strictures (58.2%).

Multicenter Study by Pérez-Cuadrado-Robles E, Bronswijk M (…) van der Merwe S et 20 al. in Gastrointest Endosc

Copyright © 2025 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

read the whole article in Gastrointest Endosc

open it in PubMed

Improved Outcomes with Elective Paraesophageal Hernia Repairs

Elective repairs of paraesophageal hernias lead to significantly better outcomes than urgent or emergent procedures.

  • Elective surgeries had a textbook outcome rate of 88.1%, compared to 58.2% for urgent and 46.7% for emergent (p < 0.001).
  • Elective repairs used laparoscopic or robotic techniques 96.3% of the time, versus only 40% for emergent cases (p < 0.001).

Surgeons should prioritize elective repairs when feasible to minimize complications and improve patient recovery.

  • Patients undergoing emergent repairs had a 6.7% mortality rate and longer hospital stays (median 3 to 13 days).

Journal Article by Crnkovic CM, Slaughter JC (…) Roth JS et 4 al. in J Am Coll Surg

Copyright © 2026 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in J Am Coll Surg

open it in PubMed

Cost Insights on Alpha Blockade for Pheochromocytoma Surgery

Selective alpha blockers lower medication expenses but yield similar surgical outcomes for pheochromocytoma.

  • Median preoperative medication cost was $19.73 for selective vs. $1,033.70 for nonselective (p < 0.001).
  • Total admission costs were nearly identical: $31,104.47 for selective vs. $31,471.90 for nonselective (p = 0.428).

Choosing selective blockers may optimize preoperative costs without compromising patient care.

  • No significant differences in length of stay or post-discharge costs based on the alpha-blockade method.

Journal Article by Kelz LR, Passman JE (…) Wachtel H et 3 al. in Ann Surg Oncol

© 2026. The Author(s).

read the whole article in Ann Surg Oncol

open it in PubMed

Imaging Predicts Complications After Pancreatic Surgery

Evaluating liver toxicity from oxaliplatin-based neoadjuvant therapy (NAT) can enhance surgical decision-making for pancreatic ductal adenocarcinoma.

  • Significant increases in splenic volume and hepatic parenchyma variability were observed post-chemotherapy (p < 0.001).
  • Low liver attenuation and heterogeneous enhancement pre-surgery were linked to severe postoperative complications (p < 0.001).

This study underscores the importance of preoperative imaging in assessing risk for complications after pancreaticoduodenectomy.

  • An inverse correlation exists between liver attenuation and complication index scores (r = -0.329, p < 0.001).

Journal Article by Tessier F, Baudouin M (…) Ronot M et 8 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Improved Liver Retraction in Robotic Hepatectomy

A new technique for liver retraction during robotic surgery minimizes trauma and enhances surgical precision.

  • Implemented in 26 robotic hepatectomies, the Clip-Pulley Maneuver (CPM) proved to be complication-free.
  • No major events (Clavien-Dindo grade III or higher) were reported, and the diaphragm remained intact in all cases.

This method allows real-time adjustments for optimal retraction without additional peritoneal punctures.

  • Typically, two clips sufficed for most procedures, with additional clips available for larger resections.

Journal Article by Ashida R, Sugiura T (…) Uesaka K et 4 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Impact of Enhanced Recovery on Liver Surgery Outcomes

High compliance with enhanced recovery programs does not significantly improve survival after liver surgery.

  • Among 1,860 patients, only 24.4% achieved high compliance.
  • Twelve-month overall survival rates were similar: 96% for high compliance vs. 92% for low compliance (p = 0.11).
  • Long-term mortality risks included metastatic disease and prolonged operative times.

Only patients with colorectal liver metastases showed improved survival linked to high compliance, emphasizing the need for careful patient selection.

  • Compliance did reduce perioperative complications, but not survival outcomes.

Journal Article by Mariatti M, Venza F (…) Brustia R et 22 al. in Ann Surg Oncol

© 2026. The Author(s).

read the whole article in Ann Surg Oncol

open it in PubMed

Total Neoadjuvant Therapy Hurts Survival in Rectal Cancer

Patients with rectal cancer who undergo total neoadjuvant therapy have significantly worse survival rates after liver surgery.

  • Median overall survival is 48.7 months for total neoadjuvant therapy patients vs 99.5 months for those who didn’t (p = .01).
  • Total neoadjuvant therapy is an independent predictor of decreased overall survival (hazard ratio 0.41).

Watch for higher rates of liver steatosis (30.8% vs 8.7%, p = .002), which may impact surgical outcomes.

Further research is required to find factors that contribute to poor outcomes in these patients.

Journal Article by Ito K, Jain AJ (…) Chun YS et 5 al. in BMC Surg

Copyright © 2026 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Predictive Model for Perineural Invasion in Colorectal Cancer

A new predictive score identifies patients at risk for perineural invasion (PNI) in colorectal cancer, impacting surgical management and outcomes.

  • PNI was found in 13.1% of patients; it predicts a 5-year overall survival of 54% versus 76.4% without PNI.
  • Key predictors include age, male sex, race, tumor location, histology, and elevated carcinoembryonic antigen (CEA) levels.
  • The Cleveland Clinic Florida score has a negative predictive value of 93%, aiding in patient selection for surgery.

Consider this score in multidisciplinary discussions for improved surgical decision-making.

Journal Article by Emile SH, Emile MH (…) Wexner SD et 2 al. in BMC Surg

Copyright © 2026 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed